Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-03

Clinical Trial Update: Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris [Phase 2]

View source ↗

Summary

A Phase 2 study of Etanercept (Enbrel) for Pemphigus Vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (Enbrel) (Etanercept)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pemphigus Vulgaris | Phase 2 | Status: COMPLETED